With a revenue increase of 114.15% in the second quarter 2026, year on year to cumulative value of $117 million, Ars Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 717,344. The productivity of Ars Pharmaceuticals Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 141 other companies have achieved higher revenue per employee. While Ars Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 1198 to 1356. Ars Pharmaceuticals Inc has 163 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SPRY Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	114.15 %	184.47 %	-67.56 %	1471.62 %	3043.4 %
Sales per Employee (TTM) $	717,344	607,276	517,043	875,902	689,196
SPRY's Total Ranking	# 1356	# 1198	# 319	# 190	# 249
Seq. Revenue Change	48.4 %	-19.25 %	-13.58 %	106.79 %	97.13 %

SPRY Company Profile >> Back to SPRY Efficiency Comparisons >> Compare SPRY Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 91
Healthcare Sector	# 142
Overall Market	# 1356

Revenue per Employee Statistics
High	Average	Low
$ 875,902	$ 667,100	$ 517,043
(Sep 30 2025)		(Dec 31 2025)

Financial Statements
Ars Pharmaceuticals Inc 's Revenue MRQ	$ 34 Millions	Visit SPRY's Income Statement
Ars Pharmaceuticals Inc 's Revenues TTM	$ 117 Millions	Visit SPRY's aggregate revenue growth
What are SPRY's Sales?		Visit SPRY's Sales by Segment

Other Ratios
Ars Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SPRY's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SPRY's Competitors
Revenue per Employee for SPRY's Suppliers
Revenue per Employee for SPRY's Customers

You may also want to know
SPRY's Sales Growth Rates	SPRY's Pe Price to earnings ratio	SPRY's Receivables Turnover Ratio	SPRY's Stock Quote
SPRY's Net Income Growth Rates	SPRY's Ps Price to Sales ratio	SPRY's Sales per Employee	SPRY's Asset Turnover Ratio
SPRY's Net Margin	SPRY's Pb Price to Book ratio	SPRY's Financial Strength Ratios	SPRY's Dividend Payout Ratio

Date modified: 2026-09-03T12:16:46+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Travere Therapeutics Inc	1,189,798.79	$ 591.330 Million	497
Heron Therapeutics Inc	1,183,648.44	$ 151.507 Million	128
Journey Medical Corp	1,175,534.48	$ 68.181 Million	58
Corcept Therapeutics Inc	1,138,100.00	$ 830.813 Million	730
Biomarin Pharmaceutical Inc	1,057,626.20	$ 3,406.614 Million	3,221
Hims and Hers Health Inc	1,055,894.35	$ 2,578.494 Million	2,442
Assembly Biosciences Inc	1,025,273.97	$ 74.845 Million	73
Sanara Medtech Inc	1,019,592.91	$ 110.116 Million	108
Ani Pharmaceuticals Inc	1,008,638.14	$ 978.379 Million	970
Meiragtx Holdings Plc	986,354.84	$ 397.501 Million	403
Arrowhead Pharmaceuticals Inc	941,624.47	$ 669.495 Million	711
Scilex Holding Company	929,647.06	$ 31.608 Million	34
Pacira Biosciences inc	900,077.20	$ 746.164 Million	829
Fortress Biotech Inc	897,217.95	$ 69.983 Million	78
Alphatec Holdings Inc	892,420.59	$ 814.780 Million	913
Merck and Co Inc	887,586.67	$ 66,569.000 Million	75,000
Nektar Therapeutics	866,492.06	$ 54.589 Million	63
Bridgebio Pharma Inc	849,903.46	$ 713.069 Million	839
Pfizer Inc	849,280.00	$ 63,696.000 Million	75,000
Syndax Pharmaceuticals Inc	845,651.01	$ 252.004 Million	298
Xilio Therapeutics Inc	843,315.79	$ 64.092 Million	76
Axsome Therapeutics Inc	839,534.05	$ 776.569 Million	925
Ionis Pharmaceuticals Inc	834,107.70	$ 1,169.419 Million	1,402
Alkermes Plc	813,488.78	$ 1,667.652 Million	2,050
Lifevantage Corp	811,421.52	$ 180.947 Million	223
Septerna Inc	760,630.77	$ 98.882 Million	130
Dyadic International Inc	760,447.40	$ 3.802 Million	5
Transmedics Group Inc	744,396.44	$ 668.468 Million	898
Aveanna Healthcare Holdings Inc	743,662.86	$ 2,602.820 Million	3,500
Veracyte Inc	721,503.31	$ 544.735 Million	755

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.